- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Patent holdings for IPC class C07D 401/14
Total number of patents in this class: 17493
10-year publication summary
|
1290
|
1214
|
1236
|
1218
|
1435
|
1472
|
1486
|
1472
|
1546
|
430
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
427 |
| Novartis AG | 11238 |
361 |
| Boehringer Ingelheim International GmbH | 4629 |
335 |
| Janssen Pharmaceutica N.V. | 3839 |
277 |
| Merck Sharp & Dohme LLC | 3689 |
263 |
| F. Hoffmann-La Roche AG | 7958 |
248 |
| Takeda Pharmaceutical Company Limited | 2961 |
233 |
| Gilead Sciences, Inc. | 1879 |
232 |
| Merck Patent GmbH | 5909 |
220 |
| Pfizer Inc. | 3322 |
190 |
| Amgen Inc. | 3779 |
181 |
| AstraZeneca AB | 3042 |
178 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
161 |
| Rigel Pharmaceuticals, Inc. | 613 |
141 |
| Hoffmann-La Roche Inc. | 3060 |
140 |
| Genentech, Inc. | 3742 |
138 |
| Vertex Pharmaceuticals Incorporated | 1581 |
130 |
| Bayer AG | 3045 |
97 |
| Bayer Pharma AG | 1096 |
97 |
| LG Chem, Ltd. | 17205 |
87 |
| Other owners | 13357 |